Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Guolin Ye
Observed name:
Guo-Lin Ye
Institution:
First People's Hospital of Foshan
Observed institutions:
Sun Yat-sen University,
Shanghai Jiao Tong University,
Ruijin Hospital,
General Hospital of Guangzhou Military Command,
Shanxi Provincial Cancer Hospital,
First People's Hospital of Foshan
show all 6
ORCID:
0000-0002-6922-3435
Observed ORCID:
0000-0002-6922-3435
OpenAlex ID:
A5055451979
Non-anthracycline-containing docetaxel and cyclophosphamide regimen is associated with sustained worse outcome compared with docetaxel, anthracycline and cyclophosphamide in neoadjuvant treatment of triple negative and HER2-positive breast cancer patients: updated follow-up data from NATT study
2016
·
Xiaosong Chen
, Guolin Ye
, et al.
·
Chinese Journal of Cancer Research
·
66
Deep learning with biopsy whole slide images for pretreatment prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer:A multicenter study
2022
·
Bao Li
, Fengling Li
, et al.
·
The Breast
·
56
Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer
2013
·
Xiaosong Chen
, Guolin Ye
, et al.
·
Breast Cancer Research and Treatment
·
52
BCL11A enhances stemness and promotes progression by activating Wnt/β-catenin signaling in breast cancer
2019
·
Lewei Zhu
, Ruilin Pan
, et al.
·
Cancer Management and Research
·
47
PDF
Single-cell and spatial transcriptome analyses revealed cell heterogeneity and immune environment alternations in metastatic axillary lymph nodes in breast cancer
2022
·
Xiaofan Mao
, Dan Zhou
, et al.
·
Cancer Immunology Immunotherapy
·
36
Plasma-Derived Extracellular Vesicles Circular RNAs Serve as Biomarkers for Breast Cancer Diagnosis
2021
·
Li Lin
, Geng-Xi Cai
, et al.
·
Frontiers in Oncology
·
35
PDF
Circ_DCAF6 potentiates cell stemness and growth in breast cancer through GLI1-Hedgehog pathway
2020
·
Guolin Ye
, Ruilin Pan
, et al.
·
Experimental and Molecular Pathology
·
30
De-escalated neoadjuvant taxane plus trastuzumab and pertuzumab with or without carboplatin in HER2-positive early breast cancer (neoCARHP): A multicentre, open-label, randomised, phase 3 trial.
2025
·
Hong-Fei Gao
, Wei Li
, et al.
·
Journal of Clinical Oncology
·
24
Clinical Evidence for Locoregional Surgery of the Primary Tumor in Patients with De Novo Stage IV Breast Cancer
2021
·
Yunfang Yu
, Huangming Hong
, et al.
·
Annals of Surgical Oncology
·
24
Adjuvant Epirubicin Plus Cyclophosphamide Followed by Taxanes With or Without Carboplatin in Early-Stage Triple-Negative Breast Cancer (RJBC 1501): A Randomized Phase III Trial
2025
·
Xiaosong Chen
, Jiahui Huang
, et al.
·
Journal of Clinical Oncology
·
18
PDF
Tumor-Targeting Extracellular Vesicles Loaded with siS100A4 for Suppressing Postoperative Breast Cancer Metastasis
2023
·
Ruiling Pan
, Tiancheng He
, et al.
·
Cellular and Molecular Bioengineering
·
16
PDF
Development and validation of a nomogram incorporating axillary lymph node ratio to predict survival in node-positive breast cancer patients after neoadjuvant chemotherapy
2018
·
Jianguo Lai
, Zihao Pan
, et al.
·
Japanese Journal of Clinical Oncology
·
14
Multivariable Models Based on Baseline Imaging Features and Clinicopathological Characteristics to Predict Breast Pathologic Response after Neoadjuvant Chemotherapy in Patients with Breast Cancer
2021
·
Peixian Chen
, Chuan Wang
, et al.
·
Breast Care
·
12
PDF
A plasma-derived extracellular vesicle mRNA classifier for the detection of breast cancer
2021
·
Geng-Xi Cai
, Li Lin
, et al.
·
Gland Surgery
·
11
PDF
A comparison of Chinese multicenter breast cancer database and SEER database
2022
·
Yingjie Niu
, Fan Zhang
, et al.
·
Scientific Reports
·
10
PDF
Noninvasive discrimination of benign and malignant breast lesions using genome-wide nucleosome profiles of plasma cell-free DNA
2021
·
Bo-Wei Han
, Geng-Xi Cai
, et al.
·
Clinica Chimica Acta
·
10
Nuclear transport maintenance of USP22-AR by Importin-7 promotes breast cancer progression
2023
·
Geng-Xi Cai
, Wei-Yao Kong
, et al.
·
Cell Death Discovery
·
9
PDF
Organoid forming potential as complementary parameter for accurate evaluation of breast cancer neoadjuvant therapeutic efficacy
2024
·
Hai-Shan Ye
, Dan Zhou
, et al.
·
British Journal of Cancer
·
7
PDF
Inhibitory effects of pigment epithelium-derived factor on epithelial-mesenchymal transition, migration and invasion of breast cancer.
2017
·
Dan Zhou
, Pengcheng Xu
, et al.
·
PubMed
·
7
Development of a nomogram to predict overall survival among non-metastatic breast cancer patients in China: a retrospective multicenter study
2018
·
Zi-Hao Pan
, Kai Chen
, et al.
·
Journal of Bio-X Research
·
3
miR-34a Reverses Doxorubicin Resistance in Breast Cancer
2020
·
Guolin Ye
, Suqun He
, et al.
·
Journal of Biomaterials and Tissue Engineering
·
1
Correlation of tumor-naive methylation-based preoperative ctDNA testing with pathologic upstaging and occult metastasis in early-stage solid tumors.
2026
·
Xiangnan Li
, Jiandong Tai
, et al.
·
Journal of Clinical Oncology
Single-Cell RNA Sequencing Findings Encourage the Application of Three-Dimensional in Vitro Cell Co-Culture to Breast Cancer Research
2021
·
Shuqing Yang
, Peixian Chen
, et al.
·
Research Square
PDF
Overall survival following locoregional surgery of the primary tumor in de novo stage IV breast cancer patients.
2018
·
Herui Yao
, Yunfang Yu
, et al.
·
Journal of Clinical Oncology
The application of albumin-bound paclitaxel in neoadjuvant chemotherapy for breast cancer
2011
·
Liao Fuyi
, Ruilin Pan
, et al.
·
Guoji yiyao weisheng daobao
Show more works
View as search
Works count:
28
Citation count:
488
H-index:
12
I10-index:
16
Year
Topic
Type